Related Experiment Video

Updated: Aug 14, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Bacterial pneumonia in the HIV-infected patient

D L Cohn1

  • 1AIDS Services, Denver Department of Health and Hospitals, Colorado.

Infectious Disease Clinics of North America
|September 1, 1991
PubMed

Insights

Bacterial pneumonia, including frequent recurrences, is more common in people with human immunodeficiency virus (HIV). Prompt antimicrobial treatment is effective, and preventive strategies like vaccines are available.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pulmonology

Background:

  • Bacterial pneumonia incidence and recurrence are elevated in human immunodeficiency virus (HIV) infection.
  • Common causative pathogens include Streptococcus pneumoniae and Haemophilus influenzae.
  • Immune system dysfunctions, such as B-cell abnormalities and neutropenia, contribute to increased susceptibility.

Purpose of the Study:

  • To review the epidemiology, pathogens, predisposing factors, and management of bacterial pneumonia in HIV-infected individuals.

Main Methods:

  • Literature review of studies on bacterial pneumonia in the context of HIV infection.

Main Results:

  • HIV infection is associated with increased rates of bacterial pneumonia, bacteremia, and recurrent infections.
  • While S. pneumoniae and H. influenzae are frequent causes, other bacteria are also implicated.
  • Patients with HIV-associated pneumonia generally respond well to appropriate antimicrobial therapy.

Conclusions:

  • Bacterial pneumonia poses a significant risk for individuals with HIV.
  • Effective treatment options exist, and preventive measures such as vaccines, immunoglobulin therapy, and antimicrobial prophylaxis should be considered.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...